CRIS Current Research Information System

PILERI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.168
EU - Europa 2.928
AS - Asia 1.715
AF - Africa 195
SA - Sud America 22
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.141
GB - Regno Unito 692
CN - Cina 624
SG - Singapore 520
IT - Italia 519
SE - Svezia 462
DE - Germania 399
VN - Vietnam 278
RU - Federazione Russa 194
IN - India 180
IE - Irlanda 130
UA - Ucraina 123
FR - Francia 103
BG - Bulgaria 68
ZA - Sudafrica 60
TG - Togo 54
EE - Estonia 50
CH - Svizzera 41
CI - Costa d'Avorio 40
FI - Finlandia 32
AT - Austria 25
NG - Nigeria 25
JO - Giordania 24
CA - Canada 21
NL - Olanda 19
ID - Indonesia 16
IR - Iran 15
BR - Brasile 14
JP - Giappone 12
HR - Croazia 11
BE - Belgio 10
HK - Hong Kong 9
PL - Polonia 9
SC - Seychelles 8
AU - Australia 6
ES - Italia 6
CZ - Repubblica Ceca 5
EG - Egitto 5
LB - Libano 5
MX - Messico 5
RO - Romania 5
UZ - Uzbekistan 5
DK - Danimarca 4
IL - Israele 4
RS - Serbia 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CL - Cile 3
HU - Ungheria 3
MD - Moldavia 3
PH - Filippine 3
PT - Portogallo 3
TH - Thailandia 3
CO - Colombia 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
LU - Lussemburgo 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 9.038
Salva come PNG Salva come JPEG
Città #
Southend 619
Fairfield 548
Chandler 450
Singapore 442
Santa Clara 252
Ashburn 250
Woodbridge 219
Houston 217
Wilmington 215
Seattle 213
Princeton 185
Cambridge 157
Dong Ket 140
Dublin 130
Boardman 118
Bologna 107
Ann Arbor 102
Westminster 65
Sofia 64
Nanjing 63
Beijing 60
Jacksonville 60
Redmond 56
Berlin 54
Lomé 54
Padova 43
Saint Petersburg 41
Abidjan 40
Bremen 39
San Diego 38
Jinan 37
New York 37
Milan 31
Turin 31
Helsinki 30
Redwood City 30
Shenyang 28
Changsha 26
Abeokuta 25
Bern 25
Amman 24
Tianjin 23
Hebei 22
Nanchang 21
Vienna 21
Falls Church 19
Hangzhou 19
Zhengzhou 19
Los Angeles 17
Mülheim 17
Des Moines 16
Jakarta 16
Norwalk 16
Rome 16
Florence 15
Olalla 15
Yubileyny 15
Dearborn 14
Guangzhou 14
Haikou 13
Hyderabad 12
Jiaxing 12
London 12
Taiyuan 11
Brussels 10
Kuban 10
Shanghai 10
Zola Predosa 10
Chengdu 9
Phoenix 8
Ravenna 8
Sault Sainte Marie 8
Shenzhen 8
Taizhou 8
Verona 8
Bühl 7
Council Bluffs 7
Lanzhou 7
Mahé 7
Ningbo 7
Piacenza 7
São Paulo 7
Toronto 7
Zanjan 7
Frankfurt Am Main 6
Fuzhou 6
Harbin 6
Hong Kong 6
Kunming 6
Medford 6
Munich 6
Nuremberg 6
Pune 6
Shijiazhuang 6
Tokyo 6
Wuhan 6
Xi'an 6
Catania 5
Gloucester 5
Lausanne 5
Totale 5.993
Salva come PNG Salva come JPEG
Nome #
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 190
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 161
Annular lesions located on the right forearm. 152
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 148
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 146
Anaplastic Large Cell Lymphoma: a critical reappraisal 144
Atopic Dermatitis and the Atopic March: What Is New? 142
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 135
Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. 134
Rosacea-like tinea incognito 133
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 132
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 128
Herpes zoster in COVID-19-positive patients 128
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 125
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 125
Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma 125
Atypical piloleiomyoma of the face presenting with central ulceration 124
Photodynamic therapy: An option in mycosis fungoides 124
Large granular lymphocytic leukaemia mimicking ulcer of the lower limb 123
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 121
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 120
Mycosis fungoides following pityriasis lichenoides: An exceptional event or a potential evolution? 117
An asymptomatic plaque on the chest: A quiz 117
Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis: Synergistic Action or Fortuitous Coincidence? 117
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 115
Merkel cell carcinoma: a prompt diagnosis to increase survival 114
Brownish asymptomatic lesions on the arms and legs 114
Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. 112
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 111
Dermatofibrosarcoma protuberans secondary to a decorative tattoo: An Isotattootopic Response? 110
Vemurafenib mucosal side-effect. 109
Alopecia areata-like mycosis fungoides: Lions for lambs 109
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 108
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 107
Leukemia cutis in a Ph+ ALL patient treated with ponatinib 107
Management of malignant cutaneous wounds in oncologic patients 104
Extramedullary metastatic plasmacytoma in a multiple myeloma patient 103
Indolent lymphoma: the pathologist's viewpoint 102
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients 101
Persistent agmination of lymphomatoid papulosis: an ongoing debate. 101
The karma of Kikuchi's disease. 100
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy 100
Peripheral T-cell lymphoma. 99
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? 99
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 99
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia 99
Cutaneous adverse-events in patients treated with Ibrutinib 98
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model 97
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 95
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 95
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 95
Granulomatous tattoo reaction in a nivolumab-treated patient 94
Erythematous induration of the chest 93
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 93
A large mass and erythematous-violaceous plaques - Ein großer tumor und livid-erythematöse plaques 92
Lymphoma classification: Past, present and future 91
Verrucous mycosis fungoides. 90
Multiple familial trichodiscomas. 89
Lymphoma classification: the quiet after the storm. 89
Chilblain lesions after COVID-19 mRNA vaccine 89
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 88
Papular mycosis fungoides: a new casa expanding the spectrum of phenotypic and clinical findings 87
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 84
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 84
The role of myeloid derived suppressor cells in mycosis fungoides 83
Squamous cell carcinoma developed after ingenol mebutate therapy: A possible consequence of the treatment? 83
Mycosis fungoides: disease evolution of the "lion queen" revisited. 77
Sézary Syndrome without erythroderma featuring a CD30+ progression 77
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 75
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 74
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 70
null 68
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis 68
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum? 67
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 65
Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection 64
Erosive pustular dermatosis of the leg: An uncommon entity? 62
Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas? 62
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 62
Micosi fungoide: nuovi orizzonti dal microambiente? 61
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine 60
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides 60
Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP) 58
Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient 54
null 49
Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal 49
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 46
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 45
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma 44
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 40
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 39
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 34
CUTANEOUS B-CELL LYMPHOMAS: UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT 33
Cutaneous composite lymphoma consisting of chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma: a unique entity and a putative pathological mechanism for cutaneous composite lymphomas 32
TOX Expression in Mycosis Fungoides and Sezary Syndrome 30
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease 29
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis 28
Who is the culprit? A toxic epidermal necrolysis case in a patient treated with rituximab plus polatuzumab 26
Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 25
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? 24
Totale 9.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020787 0 0 0 0 0 0 0 237 241 126 73 110
2020/20211.223 201 112 39 54 14 75 44 50 128 67 50 389
2021/20221.598 83 45 99 137 148 98 27 137 88 137 337 262
2022/20231.880 208 264 107 247 140 152 69 144 265 63 154 67
2023/2024593 39 109 33 48 35 109 80 44 10 36 18 32
2024/20251.715 108 363 220 213 438 103 240 30 0 0 0 0
Totale 9.359